Aveanna Healthcare Forecasts 2025 Revenue Of $2.10B-$2.12B Vs. Consensus Of $2.11B, With Adjusted EBITDA Of $190M-$194M

Benzinga
13 Mar

Full Year 2025 Guidance

The following is our guidance reflecting our current expectations for revenue and Adjusted EBITDA for the full fiscal year 2025 (year ending January 3, 2026):

  • Revenue of between $2.10 - $2.12 billion

     

Consistent with prior practice, we are not providing guidance on net income at this time due to the volatility of certain required inputs that are not available without unreasonable efforts, including future fair value adjustments associated with our interest rate swaps and caps.

  • Adjusted EBITDA of between $190 - $194 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10